UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016

PloS one, 2018-09, Vol.13 (9), p.e0203890-e0203890

2018

Link zum Volltext

Verfügbarkeit prüfen

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2022-08, Vol.13 (1), p.4931-4931, Article 4931

2022

Link zum Volltext

Verfügbarkeit prüfen

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

PLoS pathogens, 2024-04, Vol.20 (4), p.e1011680-e1011680

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES

Clinical infectious diseases, 2017-08, Vol.65 (4), p.557-565

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques

Frontiers in immunology, 2022-07, Vol.13, p.945706

2022

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2023-01, Vol.14 (1), p.333-333, Article 333

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of HIV Serostatus and Inflammation With Ascending Aortic Size

Journal of the American Heart Association, 2022-03, Vol.11 (6), p.e023997-e023997

2022

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials

Clinical and translational science, 2023-03, Vol.16 (3), p.524-535

2023

Link zum Volltext

Verfügbarkeit prüfen

Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons

AIDS research and human retroviruses, 2015-07, Vol.31 (7), p.718

2015

Link zum Volltext

Verfügbarkeit prüfen

Virologic and immunologic aspects of HIV–hepatitis C virus coinfection

AIDS (London), 2016-10, Vol.30 (16), p.2395-2404

2016

Link zum Volltext

Verfügbarkeit prüfen

Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)

Journal of patient-reported outcomes, 2023-01, Vol.7 (1), p.8-8, Article 8

2023

Link zum Volltext

Verfügbarkeit prüfen

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

JCI insight, 2022-12, Vol.7 (24)

2022

Link zum Volltext

Verfügbarkeit prüfen

Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.256-268

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to Drs de Grooth and Parienti

The Journal of infectious diseases, 2024-05, Vol.229 (5), p.1596-1596

2024

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

Open forum infectious diseases, 2014-12, Vol.1 (3), p.ofu104-ofu104

2014

Link zum Volltext

Verfügbarkeit prüfen

Demographics and natural history of HIV-1-infected spontaneous controllers of viremia

AIDS (London), 2017-05, Vol.31 (8), p.1091-1098

2017

Link zum Volltext

Verfügbarkeit prüfen

Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV)

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e571-e579

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1207-1213

2022

Link zum Volltext

Verfügbarkeit prüfen

Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation

AIDS (London), 2024-03, Vol.38 (3), p.317

2024

Link zum Volltext

Verfügbarkeit prüfen

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

The Journal of infectious diseases, 2018-09, Vol.218 (9), p.1394-1403

2018

Link zum Volltext

Verfügbarkeit prüfen

Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019

Clinical infectious diseases, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

The Journal of infectious diseases, 2023-08, Vol.228 (Supplement_2), p.S83-S91

2023

Link zum Volltext

Verfügbarkeit prüfen

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients

The Journal of infectious diseases, 2023-08, Vol.228 (Supplement_2), p.S77-S82

2023

Link zum Volltext

Verfügbarkeit prüfen

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Clinical infectious diseases, 2023-10, Vol.77 (7), p.941-949

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(81)
Dissertationen
(1)

Sprache

Englisch
(82)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(58)
Humans
(40)
Infectious Diseases
(34)
Immunology
(27)
Microbiology
(23)
Adult
(22)
Covid-19
(20)
Male
(20)
Hiv
(19)
Middle Aged
(17)
Female
(16)
Human Immunodeficiency Virus
(12)
Clinical Trials
(11)
Coronaviruses
(11)
Hepatitis C
(10)
Risk Factors
(10)
Sars-Cov-2
(10)
Severe Acute Respiratory Syndrome Coronavirus 2
(10)
Hiv Infections - Complications
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Association of HIV Serostatus and Inflammation With Ascending Aortic Size

Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials

Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons

Virologic and immunologic aspects of HIV–hepatitis C virus coinfection

Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co‐infected patients in Ukraine

Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus

Response to Drs de Grooth and Parienti

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

Demographics and natural history of HIV-1-infected spontaneous controllers of viremia

Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV)

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Suchergebnisse filtern